Transcriptomics and proteomics in human African trypanosomiasis: current status and perspectives

Area of Science:

• Parasitology
• Molecular Biology
• Public Health

Background:

• Human African trypanosomiasis (sleeping sickness) is a neglected vector-borne parasitic disease caused by Trypanosoma brucei.
• It results in 1.5 million disability-adjusted life years lost annually and is a major cause of mortality in Africa.
• Current diagnostic and treatment methods are complex, expensive, and have severe side effects.

Purpose of the Study:

• To review the contributions of transcriptomic and proteomic analyses in identifying molecular targets for sleeping sickness.
• To explore how these technologies can advance early diagnosis, epidemiology, chemotherapy, and vaccine development.
• To highlight the potential of omics approaches in combating this disease.

Main Methods:

• Review of transcriptomic and proteomic studies on Trypanosoma brucei.
• Analysis of molecular mechanisms in parasite-vector and host-parasite interactions.
• Identification of potential diagnostic and therapeutic targets.

Main Results:

• Transcriptomic and proteomic technologies are yielding promising results in understanding parasite biology.
• These studies have identified numerous potential molecular targets and biological pathways.
• These targets are crucial for developing new diagnostic and therapeutic tools.

Conclusions:

• Transcriptomics and proteomics are vital for advancing sleeping sickness research.
• These omics approaches are expected to facilitate the development of novel tools for diagnosis and treatment.
• Further investigation into identified targets will aid in controlling and potentially eradicating this neglected disease.